BenevolentAI: AI for Drug Discovery

Their platform ingests millions of scientific papers, clinical trial results, and chemical databases to create a massive 'Knowledge Graph'. AI algorithms then traverse this graph to find hidden relationships between genes, diseases, and drugs. It's like having a researcher who has read every medical paper ever published.

Their platform ingests millions of scientific papers, clinical trial results, and chemical databases to create a massive 'Knowledge Graph'. AI algorithms then traverse this graph to find hidden relationships between genes, diseases, and drugs. It's like having a researcher who has read every medical paper ever published.

A famous success story occurred during the COVID-19 pandemic. In early 2020, BenevolentAI’s system identified that Baricitinib, a drug for rheumatoid arthritis, might be effective against the virus. They published the finding, trials were fast-tracked, and the drug was subsequently approved by the FDA and WHO, saving thousands of lives.

A famous success story occurred during the COVID-19 pandemic. In early 2020, BenevolentAI’s system identified that Baricitinib, a drug for rheumatoid arthritis, might be effective against the virus. They published the finding, trials were fast-tracked, and the drug was subsequently approved by the FDA and WHO, saving thousands of lives.

This approach moves biology from a trial-and-error discipline to a data science discipline. It allows for the repurposing of existing drugs and the precise design of new molecules.

This approach moves biology from a trial-and-error discipline to a data science discipline. It allows for the repurposing of existing drugs and the precise design of new molecules.

Frequently asked questions